APHAR - Austrian Pharmacological Society - Österreichische Pharmakologische Gesellschaft

Austrian Pharmacological Society
30th Scientific Symposium of APHAR

Linz, 28–30 September 2026

Download Poster PDF:
Size A4, A3, A2

General Information Abstract Submission Registration Scientific Program Accomodation Sponsors

S c i e n t i f i c P r o g r a m :

Please click on the icon on the left for the Preliminary Program .

P r e m e e t i n g W o r k s h o p :
Monday, 28 September 2026: 12:30 –15:00
"Science with Responsibility – Clinical Research at the Interface of Science, Ethics and Regulation" (organised by Eva-Maria Zebedin)
Drug development requires balancing scientific innovation, ethical principles, regulatory requirements, and the perspectives of multiple stakeholders, including patients and the pharmaceutical industry. This interactive workshop is intended for participants interested in drug development and clinical or translational research. No prior expertise in ethics or regulatory science is required.
The first part will provide a concise introduction to the ethical, scientific, and regulatory frameworks that shape drug development.
In the second part, participants will work in small groups on realistic case scenarios from the perspectives of investigators, sponsors, regulators, ethics committees, clinicians, or patients. They will present and discuss their positions and jointly reach a decision, mirroring real-world drug development.
Cases may address preclinical data packages, first-in-human trials, placebo use, vulnerable populations, evidence gaps, or early access to promising therapies. The aim is to explore areas of agreement and conflict and to develop transparent, well-reasoned approaches to complex decisions. The workshop offers a practical opportunity to experience how such decisions are negotiated across disciplines and stakeholder perspectives.
Participation is free of charge for participants registered for the APHAR 2026 Scientific Symposium. However, in order to allow for making the necessary arrangements, please
register here for this workshop
(Note: no automatic confirmation can be issued due to technical constraints.)
Information for Presenting Authors: All presentations shall be given in English.
Short oral communications:
The presentation should be 10 minutes, followed by a 5 min discussion. The lecture room is equipped for presentations with PowerPoint (PC format).
Speakers should upload their presentation to the computer in the lecture hall using a USB stick prior to the designated session. It is not recommended to try to connect a personal laptop.
Poster presentations:
Posters shall be mounted on the first day prior to the start of the program and should be left on display for both days of the meeting.
Poster dimensions: height: 119 cm, width: 84 cm (A0 portrait format).
Presenting authors are requested to attend their posters during the designated poster tour session.
P u b l i s h e d A b s t r a c t s :
Intrinsic Activity, 2026; 14(Suppl.1)

Abstracts wlil be published in Intrinsic Activity, 2026; 14(Suppl.1) one week before the meeting.

11.08.2026 Austrian Pharmacological Society

S c i e n t i f i c P r o g r a m :	Please click on the icon on the left for the Preliminary Program .
P r e m e e t i n g W o r k s h o p :	Monday, 28 September 2026: 12:30 –15:00 *"Science with Responsibility – Clinical Research at the Interface of Science, Ethics and Regulation"* (organised by Eva-Maria Zebedin) Drug development requires balancing scientific innovation, ethical principles, regulatory requirements, and the perspectives of multiple stakeholders, including patients and the pharmaceutical industry. This interactive workshop is intended for participants interested in drug development and clinical or translational research. No prior expertise in ethics or regulatory science is required. The first part will provide a concise introduction to the ethical, scientific, and regulatory frameworks that shape drug development. In the second part, participants will work in small groups on realistic case scenarios from the perspectives of investigators, sponsors, regulators, ethics committees, clinicians, or patients. They will present and discuss their positions and jointly reach a decision, mirroring real-world drug development. Cases may address preclinical data packages, first-in-human trials, placebo use, vulnerable populations, evidence gaps, or early access to promising therapies. The aim is to explore areas of agreement and conflict and to develop transparent, well-reasoned approaches to complex decisions. The workshop offers a practical opportunity to experience how such decisions are negotiated across disciplines and stakeholder perspectives. Participation is *free of charge* for participants registered for the APHAR 2026 Scientific Symposium. However, in order to allow for making the necessary arrangements, please *register here* *for this workshop* (Note: no automatic confirmation can be issued due to technical constraints.)
Information for Presenting Authors:	All presentations shall be given in English. Short oral communications: The presentation should be 10 minutes, followed by a 5 min discussion. The lecture room is equipped for presentations with PowerPoint (PC format). Speakers should upload their presentation to the computer in the lecture hall using a USB stick prior to the designated session. It is not recommended to try to connect a personal laptop. Poster presentations: Posters shall be mounted on the first day prior to the start of the program and should be left on display for both days of the meeting. Poster dimensions: height: 119 cm, width: 84 cm (A0 portrait format). Presenting authors are requested to attend their posters during the designated poster tour session.
P u b l i s h e d A b s t r a c t s :	Abstracts wlil be published in Intrinsic Activity, 2026; 14(Suppl.1) one week before the meeting.
11.08.2026 Austrian Pharmacological Society